Dusica Maysinger

Dusica Maysinger

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2005 in Journal of Molecular Medicine
Verified
Journal Article
Closed access
PDF file
JLJasmina Lovrić
Jasmina Lovrić
HBHassan S. Bazzi
Hassan S. Bazzi
YCYan Cuie
Yan Cuie
GFGenevieve R. A. Fortin
Genevieve R. A. Fortin
FWFrançoise M. Winnik
Françoise M. Winnik
DMDusica Maysinger
Dusica Maysinger

12 February 2007 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
ACAngela O Choi
Angela O Choi
SCSung Ju Cho
Sung Ju Cho
JDJulie Desbarats
Julie Desbarats
JLJasmina Lovrić
Jasmina Lovrić
DMDusica Maysinger
Dusica Maysinger
Background: Neuroblastoma, a frequently occurring solid tumour in children, remains a therapeutic challenge as existing imaging tools are inadequate for proper and accurate diagnosis, resulting in treatment failures. Nanoparticles have recently been introduced to the field of cancer research and promise remarkable improvements in diagnostics, targeting and drug delivery. Among these nanoparticles, quantum dots (QDs) are highly appealing due to their manipulatable surfaces, yielding multifunctional QDs applicable in different biological models. The biocompatibility of these QDs, however, remains questionable. Results: We show here that QD surface modifications with N-acetylcysteine (NAC) alter QD physical and biological properties. In human neuroblastoma (SH-SY5Y) cells, NAC modified QDs were internalized to a lesser extent and were less cytotoxic than unmodified QDs. Cytotoxicity was correlated with Fas upregulation on the surface of treated cells. Alongside the increased expression of Fas, QD treated cells had increased membrane lipid peroxidation, as measured by the fluorescent BODIPY-C11 dye. Moreover, peroxidized lipids were detected at the mitochondrial level, contributing to the impairment of mitochondrial functions as shown by the MTT reduction assay and imaged with confocal microscopy using the fluorescent JC-1 dye. Conclusion: QD core and surface compositions, as well as QD stability, all influence nanoparticle internalization and the consequent cytotoxicity. Cadmium telluride QD-induced toxicity involves the upregulation of the Fas receptor and lipid peroxidation, leading to impaired neuroblastoma cell functions. Further improvements of nanoparticles and our understanding of the underlying mechanisms of QD-toxicity are critical for the development of new nanotherapeutics or diagnostics in nano-oncology.

27 October 2007 in Journal of Molecular Medicine
Verified
Journal Article
Closed access
PDF file
ACAngela O. Choi
Angela O. Choi
SBShelley E. Brown
Shelley E. Brown
MSMoshe Szyf
Moshe Szyf
DMDusica Maysinger
Dusica Maysinger

1 November 2017 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
AMAndrea M. Mebert
Andrea M. Mebert
CBCarolyn J. Baglole
Carolyn J. Baglole
Martin DesimoneMartin Desimone
Martin Desimone
DMDusica Maysinger
Dusica Maysinger

Verified
Journal Article
Open access
PDF file
HTHussein Traboulsi
Hussein Traboulsi
NGNecola Guerrina
Necola Guerrina
MIMatthew Iu
Matthew Iu
DMDusica Maysinger
Dusica Maysinger
Parisa A. AriyaParisa A. Ariya
Parisa A. Ariya
CBCarolyn Baglole
Carolyn Baglole
Air pollution of anthropogenic origin is largely from the combustion of biomass (e.g., wood), fossil fuels (e.g., cars and trucks), incinerators, landfills, agricultural activities and tobacco smoke. Air pollution is a complex mixture that varies in space and time, and contains hundreds of compounds including volatile organic compounds (e.g., benzene), metals, sulphur and nitrogen oxides, ozone and particulate matter (PM). PM0.1 (ultrafine particles (UFP)), those particles with a diameter less than 100 nm (includes nanoparticles (NP)) are considered especially dangerous to human health and may contribute significantly to the development of numerous respiratory and cardiovascular diseases such as chronic obstructive pulmonary disease (COPD) and atherosclerosis. Some of the pathogenic mechanisms through which PM0.1 may contribute to chronic disease is their ability to induce inflammation, oxidative stress and cell death by molecular mechanisms that include transcription factors such as nuclear factor κB (NF-κB) and nuclear factor (erythroid-derived 2)-like 2 (Nrf2). Epigenetic mechanisms including non-coding RNA (ncRNA) may also contribute towards the development of chronic disease associated with exposure to PM0.1. This paper highlights emerging molecular concepts associated with inhalational exposure to PM0.1 and their ability to contribute to chronic respiratory and systemic disease.

1 March 2007 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
DMDusica Maysinger
Dusica Maysinger
JLJasmina Lovrić
Jasmina Lovrić
AEAdi Eisenberg
Adi Eisenberg
RSRadoslav Savić
Radoslav Savić